Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm - Seite 2

This year, the global PFA market value is estimated to be $232 million with the potential to grow to $2.9 billion by the year 2028.¹ The Electrophysiology Mapping and Ablation Devices Market Insights reports provide in-depth data and analysis of clinical practice, patient journey, and competing therapies, allowing medical device companies and physicians to make more informed and strategic decisions.

The new reports highlight revised forecasts in the space for four geographies, covering:

• Electrophysiology Mapping and Ablation Devices – Market Insights – United States
  The US EP mapping and ablation device market, which includes PFA among other technologies, is projected to experience strong growth through 2028 and is anticipated to reach a total market value of $7.2 billion by that year, driven strongly by PFA uptake. The COVID-19 pandemic had a significant impact on certain EP ablation procedures in 2020, followed by a period of recovery. Growth in market revenues will be driven by increasing ablation procedure volumes and the uptake of premium-priced devices. Innovations in this space will lead to improved outcomes and procedure growth.
• Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
  The European EP mapping and ablation device market, projected to experience moderate growth through 2028 due to increasing ablation procedure volumes, technological advancements, and the uptake of premium-priced devices, is anticipated to reach a total market value of $3.7 billion.
• Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
  The Japanese EP mapping and ablation device market, having largely recovered from the COVID-19 pandemic, will resume moderate growth over the remainder of the forecast period. This growth is supported by increasing AF ablation procedure volumes, the emergence and adoption of novel technology, including PFA and hybrid AF ablation systems. The total market value is projected to reach $1.9 billion by the year 2028.
• Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
  Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume pre-pandemic growth trends in the near term. Going forward, the Asia Pacific EP mapping and ablation device market will expand rapidly, supported by rising AF treatment volumes, an expanding patient pool, improving access to healthcare, and the emergence of newer, premium-priced devices. Although cost constraints and a challenging reimbursement environment will hinder the pace of market expansion to some extent, the total market value is projected to reach $3.6 billion by the year 2028.

To learn more about MedTech Insights Research Reports, visit MedTech Insights - Research Reports – Clarivate.